Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6] | 93-302

Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6] | 93-302 | Gentaur UK, US & Europe Distribution

Host: Human

Reactivity: Virus

Homology: N/A

Immunogen: full length recombinant Nucleocapsid Protein

Research Area: Infectious Disease, COVID-19

Tested Application: E

Application: Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test.

Specificiy: Antibody recognizes 2019-nCoV Nucleocapsid Protein

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: ≥95 %

Clonality: Recombinant Monoclonal

Clone: 4A6

Isotype: Human IgG1

Conjugate: Unconjugated

Physical State: Liquid

Buffer: PBS, pH 7.4

Concentration: 5.0 mg/ml (+/- 10 %)

Storage Condition: 24 months from manufacturing at <-20 ˚C; 1 month, 2 to 8 ˚C under sterile conditions.

Alternate Name: SARS-CoV-2 (COVID-19) Nucleocapsid Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) , Nucleocapsid protein, N protein, Nucleocapsid Phosphoprotein

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.